kojic acid has been researched along with Carcinoma, Hepatocellular in 2 studies
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suthiram, KT | 1 |
| Ghazi, T | 1 |
| Abdul, NS | 1 |
| Chuturgoon, AA | 1 |
| Oncul, S | 1 |
| Karakaya, G | 1 |
| Dilsiz Aytemir, M | 1 |
| Ercan, A | 1 |
2 other studies available for kojic acid and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Kojic acid induces oxidative stress and anti-inflammatory effects in human hepatocellular carcinoma (HepG2) cells.
Topics: Anti-Inflammatory Agents; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Inflammation; Liver Neopl | 2023 |
A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Drug Resistance, Neoplasm; H | 2019 |